0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Hospital-Acquired Infection Control - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: September 2024
|
Report Code: QYRE-Auto-18O1877
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Hospital Acquired Infection Control Market Insights Forecast to 2028
BUY CHAPTERS

Hospital-Acquired Infection Control - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-18O1877
Report
September 2024
Pages:91
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Hospital-Acquired Infection Control - Market Size

The global market for Hospital-Acquired Infection Control was estimated to be worth US$ 5702.2 million in 2023 and is forecast to a readjusted size of US$ 6985.5 million by 2030 with a CAGR of 2.9% during the forecast period 2024-2030

Hospital-Acquired Infection Control - Market

Hospital-Acquired Infection Control - Market

HAI is a term used to describe all infections that do not stem from the patient’s original diagnosis on admission.
HAIs are caused by bacteria, viruses or parasites that originate from the hospital environment, contaminated equipment, staff, or other patients. The most common types are urinary tract infections, chest infections, and surgical wound infections.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Hospital-Acquired Infection Control, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Hospital-Acquired Infection Control by region & country, by Type, and by Application.
The Hospital-Acquired Infection Control market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hospital-Acquired Infection Control.
Market Segmentation

Scope of Hospital-Acquired Infection Control - Market Report

Report Metric Details
Report Name Hospital-Acquired Infection Control - Market
Forecasted market size in 2030 US$ 6985.5 million
CAGR 2.9%
Forecasted years 2024 - 2030
Segment by Type:
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company GSK, Merck, Pfizer, 3M, Abbott, BD, Cepheid, Getinge Group
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Hospital-Acquired Infection Control manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Hospital-Acquired Infection Control in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Hospital-Acquired Infection Control in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Hospital-Acquired Infection Control - Market size in 2030?

Ans: The Hospital-Acquired Infection Control - Market size in 2030 will be US$ 6985.5 million.

Who are the main players in the Hospital-Acquired Infection Control - Market report?

Ans: The main players in the Hospital-Acquired Infection Control - Market are GSK, Merck, Pfizer, 3M, Abbott, BD, Cepheid, Getinge Group

What are the Application segmentation covered in the Hospital-Acquired Infection Control - Market report?

Ans: The Applications covered in the Hospital-Acquired Infection Control - Market report are Hospitals and ICUs, Outpatient Care Centers, Long-term Care Facilities (LTCFs)

What are the Type segmentation covered in the Hospital-Acquired Infection Control - Market report?

Ans: The Types covered in the Hospital-Acquired Infection Control - Market report are Catheter-associated Urinary Tract Infections (CAUTIs), Surgical Site Infections (SSIs), Central Line-associated Bloodstream Infections (CLABSIs), Respiratory Infections

Recommended Reports

Infection Control

Hospital Equipment

Infection Diagnosis

1 Market Overview
1.1 Hospital-Acquired Infection Control Product Introduction
1.2 Global Hospital-Acquired Infection Control Market Size Forecast
1.3 Hospital-Acquired Infection Control Market Trends & Drivers
1.3.1 Hospital-Acquired Infection Control Industry Trends
1.3.2 Hospital-Acquired Infection Control Market Drivers & Opportunity
1.3.3 Hospital-Acquired Infection Control Market Challenges
1.3.4 Hospital-Acquired Infection Control Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Hospital-Acquired Infection Control Players Revenue Ranking (2023)
2.2 Global Hospital-Acquired Infection Control Revenue by Company (2019-2024)
2.3 Key Companies Hospital-Acquired Infection Control Manufacturing Base Distribution and Headquarters
2.4 Key Companies Hospital-Acquired Infection Control Product Offered
2.5 Key Companies Time to Begin Mass Production of Hospital-Acquired Infection Control
2.6 Hospital-Acquired Infection Control Market Competitive Analysis
2.6.1 Hospital-Acquired Infection Control Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Hospital-Acquired Infection Control Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hospital-Acquired Infection Control as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Catheter-associated Urinary Tract Infections (CAUTIs)
3.1.2 Surgical Site Infections (SSIs)
3.1.3 Central Line-associated Bloodstream Infections (CLABSIs)
3.1.4 Respiratory Infections
3.2 Global Hospital-Acquired Infection Control Sales Value by Type
3.2.1 Global Hospital-Acquired Infection Control Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Hospital-Acquired Infection Control Sales Value, by Type (2019-2030)
3.2.3 Global Hospital-Acquired Infection Control Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals and ICUs
4.1.2 Outpatient Care Centers
4.1.3 Long-term Care Facilities (LTCFs)
4.2 Global Hospital-Acquired Infection Control Sales Value by Application
4.2.1 Global Hospital-Acquired Infection Control Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Hospital-Acquired Infection Control Sales Value, by Application (2019-2030)
4.2.3 Global Hospital-Acquired Infection Control Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Hospital-Acquired Infection Control Sales Value by Region
5.1.1 Global Hospital-Acquired Infection Control Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Hospital-Acquired Infection Control Sales Value by Region (2019-2024)
5.1.3 Global Hospital-Acquired Infection Control Sales Value by Region (2025-2030)
5.1.4 Global Hospital-Acquired Infection Control Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Hospital-Acquired Infection Control Sales Value, 2019-2030
5.2.2 North America Hospital-Acquired Infection Control Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Hospital-Acquired Infection Control Sales Value, 2019-2030
5.3.2 Europe Hospital-Acquired Infection Control Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Hospital-Acquired Infection Control Sales Value, 2019-2030
5.4.2 Asia Pacific Hospital-Acquired Infection Control Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Hospital-Acquired Infection Control Sales Value, 2019-2030
5.5.2 South America Hospital-Acquired Infection Control Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Hospital-Acquired Infection Control Sales Value, 2019-2030
5.6.2 Middle East & Africa Hospital-Acquired Infection Control Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Hospital-Acquired Infection Control Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Hospital-Acquired Infection Control Sales Value
6.3 United States
6.3.1 United States Hospital-Acquired Infection Control Sales Value, 2019-2030
6.3.2 United States Hospital-Acquired Infection Control Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Hospital-Acquired Infection Control Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Hospital-Acquired Infection Control Sales Value, 2019-2030
6.4.2 Europe Hospital-Acquired Infection Control Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Hospital-Acquired Infection Control Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Hospital-Acquired Infection Control Sales Value, 2019-2030
6.5.2 China Hospital-Acquired Infection Control Sales Value by Type (%), 2023 VS 2030
6.5.3 China Hospital-Acquired Infection Control Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Hospital-Acquired Infection Control Sales Value, 2019-2030
6.6.2 Japan Hospital-Acquired Infection Control Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Hospital-Acquired Infection Control Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Hospital-Acquired Infection Control Sales Value, 2019-2030
6.7.2 South Korea Hospital-Acquired Infection Control Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Hospital-Acquired Infection Control Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Hospital-Acquired Infection Control Sales Value, 2019-2030
6.8.2 Southeast Asia Hospital-Acquired Infection Control Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Hospital-Acquired Infection Control Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Hospital-Acquired Infection Control Sales Value, 2019-2030
6.9.2 India Hospital-Acquired Infection Control Sales Value by Type (%), 2023 VS 2030
6.9.3 India Hospital-Acquired Infection Control Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 GSK
7.1.1 GSK Profile
7.1.2 GSK Main Business
7.1.3 GSK Hospital-Acquired Infection Control Products, Services and Solutions
7.1.4 GSK Hospital-Acquired Infection Control Revenue (US$ Million) & (2019-2024)
7.1.5 GSK Recent Developments
7.2 Merck
7.2.1 Merck Profile
7.2.2 Merck Main Business
7.2.3 Merck Hospital-Acquired Infection Control Products, Services and Solutions
7.2.4 Merck Hospital-Acquired Infection Control Revenue (US$ Million) & (2019-2024)
7.2.5 Merck Recent Developments
7.3 Pfizer
7.3.1 Pfizer Profile
7.3.2 Pfizer Main Business
7.3.3 Pfizer Hospital-Acquired Infection Control Products, Services and Solutions
7.3.4 Pfizer Hospital-Acquired Infection Control Revenue (US$ Million) & (2019-2024)
7.3.5 3M Recent Developments
7.4 3M
7.4.1 3M Profile
7.4.2 3M Main Business
7.4.3 3M Hospital-Acquired Infection Control Products, Services and Solutions
7.4.4 3M Hospital-Acquired Infection Control Revenue (US$ Million) & (2019-2024)
7.4.5 3M Recent Developments
7.5 Abbott
7.5.1 Abbott Profile
7.5.2 Abbott Main Business
7.5.3 Abbott Hospital-Acquired Infection Control Products, Services and Solutions
7.5.4 Abbott Hospital-Acquired Infection Control Revenue (US$ Million) & (2019-2024)
7.5.5 Abbott Recent Developments
7.6 BD
7.6.1 BD Profile
7.6.2 BD Main Business
7.6.3 BD Hospital-Acquired Infection Control Products, Services and Solutions
7.6.4 BD Hospital-Acquired Infection Control Revenue (US$ Million) & (2019-2024)
7.6.5 BD Recent Developments
7.7 Cepheid
7.7.1 Cepheid Profile
7.7.2 Cepheid Main Business
7.7.3 Cepheid Hospital-Acquired Infection Control Products, Services and Solutions
7.7.4 Cepheid Hospital-Acquired Infection Control Revenue (US$ Million) & (2019-2024)
7.7.5 Cepheid Recent Developments
7.8 Getinge Group
7.8.1 Getinge Group Profile
7.8.2 Getinge Group Main Business
7.8.3 Getinge Group Hospital-Acquired Infection Control Products, Services and Solutions
7.8.4 Getinge Group Hospital-Acquired Infection Control Revenue (US$ Million) & (2019-2024)
7.8.5 Getinge Group Recent Developments
8 Industry Chain Analysis
8.1 Hospital-Acquired Infection Control Industrial Chain
8.2 Hospital-Acquired Infection Control Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Hospital-Acquired Infection Control Sales Model
8.5.2 Sales Channel
8.5.3 Hospital-Acquired Infection Control Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Hospital-Acquired Infection Control Market Trends
    Table 2. Hospital-Acquired Infection Control Market Drivers & Opportunity
    Table 3. Hospital-Acquired Infection Control Market Challenges
    Table 4. Hospital-Acquired Infection Control Market Restraints
    Table 5. Global Hospital-Acquired Infection Control Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Hospital-Acquired Infection Control Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Hospital-Acquired Infection Control Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Hospital-Acquired Infection Control Product Type
    Table 9. Key Companies Time to Begin Mass Production of Hospital-Acquired Infection Control
    Table 10. Global Hospital-Acquired Infection Control Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hospital-Acquired Infection Control as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Hospital-Acquired Infection Control Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Hospital-Acquired Infection Control Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Hospital-Acquired Infection Control Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Hospital-Acquired Infection Control Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Hospital-Acquired Infection Control Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Hospital-Acquired Infection Control Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Hospital-Acquired Infection Control Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Hospital-Acquired Infection Control Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Hospital-Acquired Infection Control Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Hospital-Acquired Infection Control Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Hospital-Acquired Infection Control Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Hospital-Acquired Infection Control Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Hospital-Acquired Infection Control Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Hospital-Acquired Infection Control Sales Value by Region (2019-2024) & (%)
    Table 27. Global Hospital-Acquired Infection Control Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Hospital-Acquired Infection Control Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Hospital-Acquired Infection Control Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Hospital-Acquired Infection Control Sales Value, (2025-2030) & (US$ Million)
    Table 31. GSK Basic Information List
    Table 32. GSK Description and Business Overview
    Table 33. GSK Hospital-Acquired Infection Control Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Hospital-Acquired Infection Control Business of GSK (2019-2024)
    Table 35. GSK Recent Developments
    Table 36. Merck Basic Information List
    Table 37. Merck Description and Business Overview
    Table 38. Merck Hospital-Acquired Infection Control Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Hospital-Acquired Infection Control Business of Merck (2019-2024)
    Table 40. Merck Recent Developments
    Table 41. Pfizer Basic Information List
    Table 42. Pfizer Description and Business Overview
    Table 43. Pfizer Hospital-Acquired Infection Control Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Hospital-Acquired Infection Control Business of Pfizer (2019-2024)
    Table 45. Pfizer Recent Developments
    Table 46. 3M Basic Information List
    Table 47. 3M Description and Business Overview
    Table 48. 3M Hospital-Acquired Infection Control Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Hospital-Acquired Infection Control Business of 3M (2019-2024)
    Table 50. 3M Recent Developments
    Table 51. Abbott Basic Information List
    Table 52. Abbott Description and Business Overview
    Table 53. Abbott Hospital-Acquired Infection Control Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Hospital-Acquired Infection Control Business of Abbott (2019-2024)
    Table 55. Abbott Recent Developments
    Table 56. BD Basic Information List
    Table 57. BD Description and Business Overview
    Table 58. BD Hospital-Acquired Infection Control Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Hospital-Acquired Infection Control Business of BD (2019-2024)
    Table 60. BD Recent Developments
    Table 61. Cepheid Basic Information List
    Table 62. Cepheid Description and Business Overview
    Table 63. Cepheid Hospital-Acquired Infection Control Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Hospital-Acquired Infection Control Business of Cepheid (2019-2024)
    Table 65. Cepheid Recent Developments
    Table 66. Getinge Group Basic Information List
    Table 67. Getinge Group Description and Business Overview
    Table 68. Getinge Group Hospital-Acquired Infection Control Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Hospital-Acquired Infection Control Business of Getinge Group (2019-2024)
    Table 70. Getinge Group Recent Developments
    Table 71. Key Raw Materials Lists
    Table 72. Raw Materials Key Suppliers Lists
    Table 73. Hospital-Acquired Infection Control Downstream Customers
    Table 74. Hospital-Acquired Infection Control Distributors List
    Table 75. Research Programs/Design for This Report
    Table 76. Key Data Information from Secondary Sources
    Table 77. Key Data Information from Primary Sources
    Table 78. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Hospital-Acquired Infection Control Product Picture
    Figure 2. Global Hospital-Acquired Infection Control Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Hospital-Acquired Infection Control Sales Value (2019-2030) & (US$ Million)
    Figure 4. Hospital-Acquired Infection Control Report Years Considered
    Figure 5. Global Hospital-Acquired Infection Control Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Hospital-Acquired Infection Control Revenue in 2023
    Figure 7. Hospital-Acquired Infection Control Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Catheter-associated Urinary Tract Infections (CAUTIs) Picture
    Figure 9. Surgical Site Infections (SSIs) Picture
    Figure 10. Central Line-associated Bloodstream Infections (CLABSIs) Picture
    Figure 11. Respiratory Infections Picture
    Figure 12. Global Hospital-Acquired Infection Control Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 13. Global Hospital-Acquired Infection Control Sales Value Market Share by Type, 2023 & 2030
    Figure 14. Product Picture of Hospitals and ICUs
    Figure 15. Product Picture of Outpatient Care Centers
    Figure 16. Product Picture of Long-term Care Facilities (LTCFs)
    Figure 17. Global Hospital-Acquired Infection Control Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 18. Global Hospital-Acquired Infection Control Sales Value Market Share by Application, 2023 & 2030
    Figure 19. North America Hospital-Acquired Infection Control Sales Value (2019-2030) & (US$ Million)
    Figure 20. North America Hospital-Acquired Infection Control Sales Value by Country (%), 2023 VS 2030
    Figure 21. Europe Hospital-Acquired Infection Control Sales Value (2019-2030) & (US$ Million)
    Figure 22. Europe Hospital-Acquired Infection Control Sales Value by Country (%), 2023 VS 2030
    Figure 23. Asia Pacific Hospital-Acquired Infection Control Sales Value (2019-2030) & (US$ Million)
    Figure 24. Asia Pacific Hospital-Acquired Infection Control Sales Value by Country (%), 2023 VS 2030
    Figure 25. South America Hospital-Acquired Infection Control Sales Value (2019-2030) & (US$ Million)
    Figure 26. South America Hospital-Acquired Infection Control Sales Value by Country (%), 2023 VS 2030
    Figure 27. Middle East & Africa Hospital-Acquired Infection Control Sales Value (2019-2030) & (US$ Million)
    Figure 28. Middle East & Africa Hospital-Acquired Infection Control Sales Value by Country (%), 2023 VS 2030
    Figure 29. Key Countries/Regions Hospital-Acquired Infection Control Sales Value (%), (2019-2030)
    Figure 30. United States Hospital-Acquired Infection Control Sales Value, (2019-2030) & (US$ Million)
    Figure 31. United States Hospital-Acquired Infection Control Sales Value by Type (%), 2023 VS 2030
    Figure 32. United States Hospital-Acquired Infection Control Sales Value by Application (%), 2023 VS 2030
    Figure 33. Europe Hospital-Acquired Infection Control Sales Value, (2019-2030) & (US$ Million)
    Figure 34. Europe Hospital-Acquired Infection Control Sales Value by Type (%), 2023 VS 2030
    Figure 35. Europe Hospital-Acquired Infection Control Sales Value by Application (%), 2023 VS 2030
    Figure 36. China Hospital-Acquired Infection Control Sales Value, (2019-2030) & (US$ Million)
    Figure 37. China Hospital-Acquired Infection Control Sales Value by Type (%), 2023 VS 2030
    Figure 38. China Hospital-Acquired Infection Control Sales Value by Application (%), 2023 VS 2030
    Figure 39. Japan Hospital-Acquired Infection Control Sales Value, (2019-2030) & (US$ Million)
    Figure 40. Japan Hospital-Acquired Infection Control Sales Value by Type (%), 2023 VS 2030
    Figure 41. Japan Hospital-Acquired Infection Control Sales Value by Application (%), 2023 VS 2030
    Figure 42. South Korea Hospital-Acquired Infection Control Sales Value, (2019-2030) & (US$ Million)
    Figure 43. South Korea Hospital-Acquired Infection Control Sales Value by Type (%), 2023 VS 2030
    Figure 44. South Korea Hospital-Acquired Infection Control Sales Value by Application (%), 2023 VS 2030
    Figure 45. Southeast Asia Hospital-Acquired Infection Control Sales Value, (2019-2030) & (US$ Million)
    Figure 46. Southeast Asia Hospital-Acquired Infection Control Sales Value by Type (%), 2023 VS 2030
    Figure 47. Southeast Asia Hospital-Acquired Infection Control Sales Value by Application (%), 2023 VS 2030
    Figure 48. India Hospital-Acquired Infection Control Sales Value, (2019-2030) & (US$ Million)
    Figure 49. India Hospital-Acquired Infection Control Sales Value by Type (%), 2023 VS 2030
    Figure 50. India Hospital-Acquired Infection Control Sales Value by Application (%), 2023 VS 2030
    Figure 51. Hospital-Acquired Infection Control Industrial Chain
    Figure 52. Hospital-Acquired Infection Control Manufacturing Cost Structure
    Figure 53. Channels of Distribution (Direct Sales, and Distribution)
    Figure 54. Bottom-up and Top-down Approaches for This Report
    Figure 55. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

RELATED REPORTS

Global Hepatitis B Virus Core Antibody Diagnostic Kits Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-21N6899
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Pediatric Vaccines Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13M6952
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Poliomyelitis Vaccines Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29X7355
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Global Varicella Virus (Chickenpox) Vaccine Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-28B293
Tue Sep 09 00:00:00 UTC 2025

Add to Cart